AbbVie, Inc.
(NYSE : ABBV)

( )
ABBV PreMarket: $ () as of AM
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Do You Like Swing Trading?
Learn how we win with easy 3-5 day holds.
Be 'active' in the market while NOT being tied to your desk.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Pharmaceuticals Major
symbolcompany%chnglast%shortavg$volume
JNJJohnson & Johnson 0.48%160.690.7%$1221.58m
PFEPfizer Inc. 1.17%37.610.9%$1016.38m
MRKMerck & Co., Inc. 0.35%76.670.7%$965.72m
ABBVAbbVie, Inc. 0.94%106.901.9%$828.02m
BMYBristol-Myers Squibb Co. 1.00%64.451.0%$731.74m
LLYEli Lilly & Co. 1.65%186.011.1%$577.53m
AZNAstraZeneca Plc 1.99%50.831.2%$442.51m
GSKGlaxoSmithKline Plc 4.26%37.670.2%$213.98m
RPRXRoyalty Pharma Plc -1.12%41.650.2%$157.73m
NVSNovartis AG 0.52%87.200.2%$153.46m
VTRSViatris, Inc. 0.53%13.280.0%$128.16m
RGENRepligen Corp. 4.03%213.576.8%$89.09m
CVACCureVac NV 1.40%104.050.0%$87.46m
SNYSanofi 0.90%50.690.2%$60.91m
ATNF180 Life Sciences Corp. -4.02%10.040.0%$60.80m

Company Profile

AbbVie, Inc. is a research-based biopharmaceutical company, which engages in the development and sale of pharmaceutical products. It focuses on treating conditions such as chronic autoimmune diseases in rheumatology, gastroenterology, and dermatology; oncology, including blood cancers; virology, including hepatitis C virus (HCV) and human immunodeficiency virus (HIV); neurological disorders, such as Parkinson's disease; metabolic diseases, comprising thyroid disease and complications associated with cystic fibrosis; pain associated with endometriosis; and other serious health conditions. The company was founded on October 19, 2011 and is headquartered in North Chicago, IL.